EUVIMEDEUVIMED entdecken
Vergleichsstudie

Fasting with type 1 diabetes during Ramadan: Influence of insulin regimen in the DaR 2020 & 2022 global surveys

Nancy Elbarbary, Majd Aldeen Kallash, Muhammad Yaqoob Ahmedani, Naji Aljohani, Eman Alfadhli, Abdullah Mohammad Al Zahrani, Lobna Eltoni, Mohamed Batais, Reem Alamoudi, Khadijah Hafidh, Bachar Afandi, Mohamed Hassanein

Primary Care Diabetes · 2026-06 · 20 (3) · 379-385

DOI: 10.1016/j.pcd.2026.03.005 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Primary Care Diabetes, 2026-06. Verfasst von Nancy Elbarbary und 11 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes and Endocrine Unit, Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address: nancy_elbarbary@y…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 1, Insulin, Islam, Hypoglycemic Agents. Die Arbeit nennt 39 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND Fasting during Ramadan presents unique challenges for individuals with Type 1 Diabetes (T1D). This study analyzes the characteristics and fasting experiences of T1D patients based on their insulin regimens including basal-bolus (BB) versus premixed (PM) using data from the 2020 and 2022 Diabetes and Ramadan (DaR) Global Surveys. METHODS Participants with T1D were grouped by insulin regimen: BB (N = 1619) and PM (N = 520). Demographics, glycemic control (HbA1c), complications, fasting patterns, glycemic events, and diabetes education were assessed and compared. RESULTS BB regimens were more commonly used in the Gulf and Middle East, while PM regimens were prevalent in Southeast Asia. Glycemic control and diabetes duration were similar (mean HbA1c: 8.6% BB vs. 8.9% PM). A higher proportion of PM users completed the full 30 days of fasting (43.1% vs. 30.6%; p = 0.03). A larger proportion of BB users fasted during Shawwal (16.5% vs. 5.8%; p < 0.0001). Hypoglycemia (63% BB vs. 31.1% PM) and hyperglycemia (46.1% BB vs. 30.8% PM) were significantly higher in BB users, though hospital visits were similar. PM users had fewer diabetes-related complications overall, with the exception of neuropathy. SMBG was more common among BB users, who also received more extensive and varied education. CONCLUSION While BB regimens provide greater flexibility, they are associated with higher glycemic variability during Ramadan. PM regimens may support better fasting adherence and fewer acute glycemic events. These findings highlight the importance of individualized treatment strategies and education to support safe fasting in T1D patients.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 1InsulinIslamHypoglycemic AgentsBlood GlucoseFastingGlycemic ControlHumansFemaleMaleAdultBiomarkersGlycated HemoglobinMiddle AgedHypoglycemiaTime FactorsYoung AdultTreatment OutcomeIntermittent FastingAdolescentRisk FactorsDrug Administration Schedule

Stichwörter der Autor:innen

Basal-BolusDaR surveyFastingPremixed insulinRamadanType 1 diabetes

Substanzen

InsulinHypoglycemic AgentsBlood GlucoseBiomarkersGlycated Hemoglobinhemoglobin A1c protein, human

Autor:innen und Institutionen

  • Diabetes and Endocrine Unit, Department of Pediatrics, Faculty of Medicine, Ain Shams University, Cairo, Egypt. Electronic address: nancy_elbarbary@yahoo.com.
  • Diabetic Center and Endocrinology, King Fahad Medical City, Riyadh, Saudi Arabia.
  • Indus Hospital and Health Network, Karachi, Pakistan.
  • Consultant endocrinology and thyroid oncology, OEMC Center, King Fahad Medical City Professor of Endocrinology, College of Medicine, AL Faisal University, Saudi Arabia; Professor of Endocrinology, College of Medicine, A…
  • Department of Medicine, Taibah University, Madinah, Saudi Arabia; King Faisal Specialist Hospital and Research Center, Madinah, Saudi Arabia.
  • King Saud bin Abdulaziz University for Health Sciences, King Abdullah International Medical Research Center and Department of Family Medicine, King Abdulaziz Medical City, Jeddah, Saudi Arabia.

Zitieren

APA

Elbarbary, N., Kallash, M. A., Ahmedani, M. Y., Aljohani, N., Alfadhli, E., Al Zahrani, A. M., Eltoni, L., Batais, M., Alamoudi, R., Hafidh, K., Afandi, B., & Hassanein, M. (2026). Fasting with type 1 diabetes during Ramadan: Influence of insulin regimen in the DaR 2020 & 2022 global surveys. Primary Care Diabetes, 20(3), 379-385. https://doi.org/10.1016/j.pcd.2026.03.005

Vancouver

Elbarbary N, Kallash MA, Ahmedani MY, Aljohani N, Alfadhli E, Al Zahrani AM, et al. Fasting with type 1 diabetes during Ramadan: Influence of insulin regimen in the DaR 2020 & 2022 global surveys. Primary Care Diabetes. 2026;20(3):379-385. doi:10.1016/j.pcd.2026.03.005

BibTeX
@article{Elbarbary2026,
  author = {Elbarbary, Nancy and Kallash, Majd Aldeen and Ahmedani, Muhammad Yaqoob and Aljohani, Naji and Alfadhli, Eman and Al Zahrani, Abdullah Mohammad and Eltoni, Lobna and Batais, Mohamed and Alamoudi, Reem and Hafidh, Khadijah and Afandi, Bachar and Hassanein, Mohamed},
  title = {Fasting with type 1 diabetes during Ramadan: Influence of insulin regimen in the DaR 2020 & 2022 global surveys},
  journal = {Primary Care Diabetes},
  year = {2026},
  volume = {20},
  number = {3},
  pages = {379--385},
  doi = {10.1016/j.pcd.2026.03.005}
}
Kostenlos starten →